Clinical observation on the efficacy, safety and pharmacoeconomics of Guben Kechuan granule in treating chronic bronchitis

CHINA-JAPAN FRIENDSHIP HOSPITA0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Consistent with the diagnosis of chronic bronchitis;
•(2) The scores of main symptoms of chronic bronchitis (cough, expectoration and wheezing) were all = 1 point;
•(3) Age 18-75 years old (including 18 and 75 years old), gender is not limited;
•(4) Voluntarily participate in this clinical trial, give informed consent and sign the informed consent form.

•(1) Acute bronchitis or acute exacerbation of chronic bronchitis in recent 1 month;
•(2) Pulmonary tuberculosis, eosinophilic bronchitis, bronchial lung cancer, idiopathic pulmonary fibrosis, pneumonia, bronchial asthma, bronchiectasis, gastroesophageal reflux and other diseases with cough, expectoration or wheezing symptoms;
•(3) Have taken drugs similar to the functional indications of the test drug in the past 2 weeks;
•(4) SCR of renal function is greater than the upper limit of reference value or ALT and AST of liver function are more than 2 times of the upper limit of reference value;
•(5) Complicated with serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney, digestive and hematopoietic system;
•(6) Have a long history of alcohol and drug abuse;
•(7) Pregnant and lactating women and during the trial cannot be strictly contraception;
•(8) Have a history of allergy to test drug components;
•(9) Having intellectual disability or mental disorder;
•(10) Participated in other clinical trials in the past 3 months;
•(11) The investigator considers it inappropriate to participate in this clinical trial.

发起方

CHINA-JAPAN FRIENDSHIP HOSPITA